SIGA reports $37 million in TPOXX sales for second quarter of 2026

SIGA Technologies reported financial results for the three and six months ended June 30, 2026, in a release dated August 6, 2026. Chief Executive Officer Diem Nguyen said the company delivered approximately $37 million of TPOXX to three customers during the quarter, split between $24 million of IV TPOXX to the U.S. strategic national stockpile and $13 million of oral TPOXX to two international customers.¹

The company said this activity reflected its strategy of diversifying sales. Nguyen noted that with product deliveries spanning the U.S., Europe, and the Asia-Pacific region across multiple formulations, SIGA continues to pursue selling TPOXX across a range of regions and customers.¹

On the government contract side, SIGA disclosed a milestone. The IV TPOXX deliveries to the U.S. strategic national stockpile made during the quarter completed the last procurement order under the 19C contract.¹

The company also disclosed a capital return action taken earlier in the year. On March 26, 2026, SIGA declared a special cash dividend of $0.60 per share, which was paid on April 23, 2026, to shareholders of record as of April 7, 2026.¹

On financial position, SIGA reported product sales of $37.9 million and total revenues of $41.0 million for the quarter, with net income of $12.5 million and diluted income per share of $0.17¹. For the six-month period, product sales were $41.4 million, total revenues were $47.2 million, net income was $9.0 million, and diluted income per share was $0.13¹.

SIGA plans to hold a conference call on the results. The company will host a conference call and webcast for a business update on Thursday, August 6, 2026, at 4:30 P.M. ET.¹